Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product
Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
To compare the pharmacokinetics (PK), and pharmacodynamics (PD) of single subcutaneous (SC)
doses of 300 mg LIB003 Process 1 (P1) and Process 2 (P2) drug product in subjects with or
without statin therapy